Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 23;12(1):170.
doi: 10.1038/s41398-022-01937-7.

Individualized prediction of psychiatric readmissions for patients with major depressive disorder: a 10-year retrospective cohort study

Affiliations

Individualized prediction of psychiatric readmissions for patients with major depressive disorder: a 10-year retrospective cohort study

Ting Zhu et al. Transl Psychiatry. .

Abstract

Patients with major depressive disorder (MDD) are at high risk of psychiatric readmission while the factors associated with such adverse illness trajectories and the impact of the same factor at different follow-up times remain unclear. Based on machine learning (ML) approaches and real-world electronic medical records (EMR), we aimed to predict individual psychiatric readmission within 30, 60, 90, 180, and 365 days of an initial major depression hospitalization. In addition, we examined to what extent our prediction model could be made interpretable by quantifying and visualizing the features that drive the predictions at different follow-up times. By identifying 13,177 individuals discharged from a hospital located in western China between 2009 and 2018 with a recorded diagnosis of MDD, we established five prediction-modeling cohorts with different follow-up times. Four different ML models were trained with features extracted from the EMR, and explainable methods (SHAP and Break Down) were utilized to analyze the contribution of each of the features at both population-level and individual-level. The model showed a performance on the holdout testing dataset that decreased over follow-up time after discharge: AUC 0.814 (0.758-0.87) within 30 days, AUC 0.780 (0.728-0.833) within 60 days, AUC 0.798 (0.75-0.846) within 90 days, AUC 0.740 (0.687-0.794) within 180 days, and AUC 0.711 (0.676-0.747) within 365 days. Results add evidence that markers of depression severity and symptoms (recurrence of the symptoms, combination of key symptoms, the number of core symptoms and physical symptoms), along with age, gender, type of payment, length of stay, comorbidity, treatment patterns such as the use of anxiolytics, antipsychotics, antidepressants (especially Fluoxetine, Clonazepam, Olanzapine, and Alprazolam), physiotherapy, and psychotherapy, and vital signs like pulse and SBP, may improve prediction of psychiatric readmission. Some features can drive the prediction towards readmission at one follow-up time and towards non-readmission at another. Using such a model for decision support gives the clinician dynamic information of the patient's risk of psychiatric readmission and the specific features pulling towards readmission. This finding points to the potential of establishing personalized interventions that change with follow-up time.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study overview.
Fig. 2
Fig. 2
Flow diagram of the subject inclusion/exclusion process.
Fig. 3
Fig. 3
Cohort establishment for the 30-, 60-, 90-, 180-, and 365-day psychiatric readmission prediction.
Fig. 4
Fig. 4. Model performance in the holdout test dataset for the 30, 60, 90, 180, and 365-day psychiatric readmission prediction.
A ROC curves for 30-day psychiatric readmission prediction. B ROC curves for 60-day psychiatric readmission prediction. C ROC curves for 90-day psychiatric readmission prediction. D ROC curves for 180-day psychiatric readmission prediction. E ROC curves for 365-day psychiatric readmission prediction.
Fig. 5
Fig. 5. The impact of the 24 top important features on predictions.
A The impact of 24 top features on predictions of 30-day cohort. B The impact of 24 top features on predictions of 60-day cohort. C The impact of 24 top features on predictions of 90-day cohort. D The impact of 24 top features on predictions of 180-day cohort. E The impact of 24 top features on predictions of 365-day cohort.
Fig. 6
Fig. 6
Force plot of all features at individual patient level for the holdout test dataset of the 30-day cohort.
Fig. 7
Fig. 7. Impact of input features on 30-, 60-, 90-, 180-, and 365-day psychiatric readmission prediction for a single patient.
A Break Down plot of a particular patient for the 30-day prediction. B Break Down plot of a particular patient for the 60-day prediction. C Break Down plot of a particular patient for the 90-day prediction. D Break Down plot of a particular patient for the 180-day prediction. E Break Down plot of a particular patient for the 365-day prediction.
Fig. 8
Fig. 8
Feature interactions of 24 top important features of the 30-day cohort.

References

    1. H Whiteford, Addressing the burden of mental, neurological, and substance use disorders: Key messages from disease control priorities, 3rd edition, Lancet. 2015. - PubMed
    1. Citrome L, Jain R, Tung A, Landsman-Blumberg P, Kramer K, Ali S. Prevalence, treatment patterns, and stay characteristics associated with hospitalizations for major depressive disorder. J Affect Disord. 2019;249:378–84. doi: 10.1016/j.jad.2019.01.044. - DOI - PubMed
    1. Nordentoft M, Mortensen P, Pedersen C. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry. 2011;68:1058–64. doi: 10.1001/archgenpsychiatry.2011.113. - DOI - PubMed
    1. Cearns M, Opel N, Clark S, Kaehler C, Thalamuthu A, Heindel W, et al. Predicting rehospitalization within 2 years of initial patient admission for a major depressive episode: a multimodal machine learning approach, Translational. Psychiatry. 2019;9:285. - PMC - PubMed
    1. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373:746–58. doi: 10.1016/S0140-6736(09)60046-5. - DOI - PubMed

Publication types